Prepaire Labs
Prepaire Labs is at the forefront of personalized medicine, aiming to harmonize treatments with individual genetic profiles. Their open platform fosters collaboration to accelerate innovation in drug discovery and disease modeling. They utilize a white-box model to expedite therapeutic breakthroughs. Key products include Peptomatics™ for drug addiction treatment, and the MultiOmnis App Store, a marketplace for scientific innovation in gene editing and disease modeling. They also highlight HAiLO, an AI-driven platform for drug interaction analysis, personalized predictions, and a comprehensive database. The company is involved in genome sequencing and operates a Biobank for drug discovery. Prepaire Labs collaborates with entities like American Hospital Dubai, GenetiQ, MGI, and Chemify, with press mentions in einpresswire and MGI VIA LINKEDIN. Their business model appears to be a combination of platform access, SaaS, and potentially data services.
Prepaire Labs
Prepaire Labs is at the forefront of personalized medicine, aiming to harmonize treatments with individual genetic profiles. Their open platform fosters collaboration to accelerate innovation in drug discovery and disease modeling. They utilize a white-box model to expedite therapeutic breakthroughs. Key products include Peptomatics™ for drug addiction treatment, and the MultiOmnis App Store, a marketplace for scientific innovation in gene editing and disease modeling. They also highlight HAiLO, an AI-driven platform for drug interaction analysis, personalized predictions, and a comprehensive database. The company is involved in genome sequencing and operates a Biobank for drug discovery. Prepaire Labs collaborates with entities like American Hospital Dubai, GenetiQ, MGI, and Chemify, with press mentions in einpresswire and MGI VIA LINKEDIN. Their business model appears to be a combination of platform access, SaaS, and potentially data services.